A single-center, self-controlled, phase I clinical trial of mitoxantrone hydrochloride injection for lymph tracing for sentinel lymph node identification of breast cancer

MLA

Zhebin Liu, et al. “A Single-Center, Self-Controlled, Phase I Clinical Trial of Mitoxantrone Hydrochloride Injection for Lymph Tracing for Sentinel Lymph Node Identification of Breast Cancer.” Gland Surgery, vol. 10, Mar. 2021, pp. 992–1001. EBSCOhost, https://doi.org/10.21037/gs-20-694.

APA

Zhebin Liu, Benlong Yang, Guangyu Liu, Zhimin Shao, Jiong Wu, Shujun Wang, Shuyue Zheng, Xiaoyan Huang, & Jiajian Chen. (2021). A single-center, self-controlled, phase I clinical trial of mitoxantrone hydrochloride injection for lymph tracing for sentinel lymph node identification of breast cancer. Gland Surgery, 10, 992–1001. https://doi.org/10.21037/gs-20-694

Chicago

Zhebin Liu, Benlong Yang, Guangyu Liu, Zhimin Shao, Jiong Wu, Shujun Wang, Shuyue Zheng, Xiaoyan Huang, and Jiajian Chen. 2021. “A Single-Center, Self-Controlled, Phase I Clinical Trial of Mitoxantrone Hydrochloride Injection for Lymph Tracing for Sentinel Lymph Node Identification of Breast Cancer.” Gland Surgery 10 (March): 992–1001. doi:10.21037/gs-20-694.